Market Cap | 4.89B | P/E | - | EPS this Y | 20.00% | Ern Qtrly Grth | - |
Income | -9.42M | Forward P/E | -2,260.00 | EPS next Y | 18.50% | 50D Avg Chg | 9.00% |
Sales | 924.22M | PEG | 3.09 | EPS past 5Y | -7.00% | 200D Avg Chg | 27.00% |
Dividend | N/A | Price/Book | 1.56 | EPS next 5Y | 10.00% | 52W High Chg | -3.00% |
Recommedations | 2.00 | Quick Ratio | 2.24 | Shares Outstanding | 216.70M | 52W Low Chg | 115.00% |
Insider Own | 0.18% | ROA | 1.03% | Shares Float | 200.75M | Beta | 1.21 |
Inst Own | 118.21% | ROE | -0.30% | Shares Shorted/Prior | 22.07M/22.57M | Price | 22.60 |
Gross Margin | 50.19% | Profit Margin | -1.02% | Avg. Volume | 1,668,443 | Target Price | 20.25 |
Oper. Margin | 12.30% | Earnings Date | Oct 10 | Volume | 1,345,289 | Change | 0.09% |
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
Piper Sandler | Neutral | Aug 6, 24 |
Piper Sandler | Neutral | Apr 15, 24 |
Piper Sandler | Neutral | Jan 18, 24 |
Piper Sandler | Neutral | Oct 16, 23 |
Wells Fargo | Overweight | Aug 14, 23 |
Wells Fargo | Overweight | Jun 16, 23 |
Piper Sandler | Neutral | Dec 15, 22 |
William Blair | Outperform | Nov 22, 22 |
Piper Sandler | Neutral | Oct 10, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
BOEHM WILLIAM T | Director Director | Nov 03 | Buy | 16.055 | 2,000 | 32,110 | 26,509 | 11/03/23 |
Jones Douglas Edward | Chief Operating Offi.. Chief Operating Officer | Oct 25 | Buy | 15.1727 | 10,000 | 151,727 | 36,131 | 10/26/23 |
Lilly Jason Warren | Vice President Vice President | Oct 13 | Sell | 15.1 | 351 | 5,300 | 26,744 | 10/17/23 |
Naemura David H. | CFO CFO | Oct 11 | Buy | 15.0333 | 10,000 | 150,333 | 10,000 | 10/11/23 |
BOEHM WILLIAM T | Director Director | Aug 18 | Sell | 22.59 | 1,500 | 33,885 | 24,509 | 08/22/23 |
BOEHM WILLIAM T | Director Director | Aug 18 | Option | 15.62 | 1,500 | 23,430 | 26,009 | 08/22/23 |
BOEHM WILLIAM T | Director Director | Jan 26 | Option | 17.85 | 2,250 | 40,162 | 24,509 | 01/30/23 |
Jones Douglas Edward | Chief Operating Offi.. Chief Operating Officer | Jan 13 | Buy | 17.91 | 2,500 | 44,775 | 11,860 | 01/18/23 |
Jones Douglas Edward | Chief Operating Offi.. Chief Operating Officer | Sep 28 | Buy | 14.31 | 7,000 | 100,170 | 9,759 | 09/28/22 |
ADENT JOHN EDWARD | President & CEO President & CEO | Sep 28 | Buy | 14.37 | 22,000 | 316,140 | 80,103 | 09/28/22 |
Vetter Darci L | Director Director | Aug 16 | Buy | 21.83 | 1,100 | 24,013 | 1,384 | 08/17/22 |
BOREL JAMES C | Director Director | Jul 27 | Buy | 22.6967 | 6,500 | 147,529 | 11,773 | 08/10/22 |
Green Ronald D | Director Director | Aug 02 | Buy | 22.5 | 1,500 | 33,750 | 10,694 | 08/04/22 |
ADENT JOHN EDWARD | President & CEO President & CEO | Jul 29 | Buy | 23.07 | 17,500 | 403,725 | 58,103 | 08/02/22 |
Tobin James P | Director Director | Jul 27 | Buy | 22.98 | 2,000 | 45,960 | 14,000 | 07/28/22 |
Jones Douglas Edward | Chief Commercial Off.. Chief Commercial Officer | Jan 25 | Buy | 35.78 | 1,400 | 50,092 | 2,360 | 01/28/22 |
BOEHM WILLIAM T | Director Director | Jan 12 | Option | 15.62 | 3,000 | 46,860 | 24,242 | 01/18/22 |
BOEHM WILLIAM T | Director Director | Jan 12 | Sell | 40 | 3,000 | 120,000 | 21,242 | 01/18/22 |
Lilly Jason Warren | Vice President Vice President | Dec 23 | Option | 31.35 | 636 | 19,939 | 21,474 | 12/28/21 |
Lilly Jason Warren | Vice President Vice President | Dec 23 | Sell | 44.91 | 636 | 28,563 | 20,838 | 12/28/21 |
Quinlan Steven J. | Vice President & CFO Vice President & CFO | Apr 14 | Option | 60.43 | 13,001 | 785,650 | 26,471 | 04/14/21 |
Quinlan Steven J. | Vice President & CFO Vice President & CFO | Apr 14 | Sell | 93.93 | 13,001 | 1,221,184 | 13,470 | 04/14/21 |
ADENT JOHN EDWARD | President & CEO President & CEO | Apr 01 | Option | 63.3 | 40,464 | 2,561,371 | 60,544 | 04/01/21 |
ADENT JOHN EDWARD | President & CEO President & CEO | Apr 01 | Sell | 87.99 | 40,464 | 3,560,427 | 20,080 | 04/01/21 |
Quinlan Steven J. | Vice President & CFO Vice President & CFO | Apr 01 | Option | 60.43 | 15,000 | 906,450 | 28,470 | 04/01/21 |
Quinlan Steven J. | Vice President & CFO Vice President & CFO | Apr 01 | Sell | 88.07 | 15,000 | 1,321,050 | 13,470 | 04/01/21 |
ADENT JOHN EDWARD | President & CEO President & CEO | Apr 01 | Option | 63.3 | 4,000 | 253,200 | 20,080 | 04/01/21 |
MORRICAL TERRI A | Other Other | Mar 31 | Option | 40.46 | 600 | 24,276 | 38,175 | 03/31/21 |
MORRICAL TERRI A | Other Other | Mar 31 | Sell | 87.99 | 600 | 52,794 | 37,575 | 03/31/21 |
PAPESH BRUCE | Director Director | Jan 14 | Option | 29.16 | 30,000 | 874,800 | 66,261 | 01/14/21 |
PAPESH BRUCE | Director Director | Jan 14 | Sell | 83.4 | 30,000 | 2,502,000 | 36,261 | 01/14/21 |
Quinlan Steven J. | Vice President & CFO Vice President & CFO | Jan 07 | Option | 40.46 | 9,333 | 377,613 | 22,803 | 01/07/21 |
Quinlan Steven J. | Vice President & CFO Vice President & CFO | Jan 07 | Sell | 84.49 | 9,333 | 788,545 | 13,470 | 01/07/21 |
Lilly Jason Warren | Vice President, Inte.. Vice President, International | Jan 07 | Option | 63.3 | 12,600 | 797,580 | 24,632 | 01/07/21 |
Lilly Jason Warren | Vice President, Inte.. Vice President, International | Jan 07 | Sell | 82.91 | 11,021 | 913,751 | 13,611 | 01/07/21 |
Lilly Jason Warren | Vice President, Inte.. Vice President, International | Nov 18 | Option | 40.46 | 16,001 | 647,400 | 17,510 | 11/18/20 |
Lilly Jason Warren | Vice President, Inte.. Vice President, International | Nov 18 | Sell | 73.28 | 14,378 | 1,053,620 | 12,032 | 11/18/20 |
HERBERT JAMES L | Director Director | Oct 16 | Option | 35.34 | 25,333 | 895,268 | 67,284 | 10/16/20 |
HERBERT JAMES L | Director Director | Oct 16 | Sell | 70.91 | 25,333 | 1,796,363 | 41,951 | 10/16/20 |
HERBERT JAMES L | Director Director | Oct 02 | Option | 40.46 | 25,333 | 1,024,973 | 67,284 | 10/02/20 |
HERBERT JAMES L | Director Director | Oct 02 | Sell | 78.61 | 25,333 | 1,991,427 | 41,951 | 10/02/20 |